|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號:D101500 |
| 產(chǎn)品名稱:Daclatasvir |
| 產(chǎn)品CAS:1009119-64-5 |
| 規(guī)格含量:10mg |
| 產(chǎn)品價格:面議 |
| 聯(lián)系我們: |
|
|
|
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
D101500 |
| 名稱: |
Daclatasvir |
| 別名: |
N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-carbamic Acid C,C'-Dimethyl Ester; BMS 790052; EBP 883; |
| CAS號: |
1009119-64-5 |
| 分子式: |
C??H??N?O? |
| 外觀: |
白色至Brown Solid |
| 熔點: |
>155ºC (dec.) |
| 分子量: |
738.88 |
| 儲存: |
冰箱保存 |
| 溶解性: |
DMSO (Slightly), Methanol (Slightly) |
| 種類: |
Research Tools; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Daclatasvir, inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). |
| 參考文獻 |
|
|
|
|
|
|